Výsledky vyhledávání

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial

Publikováno v: Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N, Bliddal, H & OPERA Study Group 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group & Lorenzen, T 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N & Bliddal, H 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab : a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781–789 . https://doi.org/10.1007/s10067-016-3489-1

This study aims to investigate 1-year hand bone loss (HBL 1-year) in early rheumatoid arthritis (RA) patients treated with a methotrexate (MTX) and intra-articular triamcinolone treat-to-target strategy +/− adalimumab and to determine if HBL 6month

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1278219bd037cb38835e551f2c6113
https://vbn.aau.dk/da/publications/5f92c4a2-ba8f-4497-bb5f-3f87c3f31dd4

Zobrazit plný text záznamu

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors

Publikováno v: Annals of the Rheumatic Diseases. 69:1065-1071

ObjectivesTo investigate construct validity and responsiveness of the novel ankylosing spondylitis (AS) disease activity score (ASDAS) in patients with spondyloarthritis (SpA).MethodsIn a 46-week prospective longitudinal multicentre study of 60 patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc71ef5f8ac839a9a4a950751f9dfa1c
https://doi.org/10.1136/ard.2009.111187

Zobrazit plný text záznamu

Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging

Autor: Mette Bjørndal Axelsen, Mikkel Østergaard, U.B. Lauridsen, Merete Lund Hetland, B Ejbjerg, Morten Ilum Boesen, Henning Bliddal, O Majgaard, Olga Kubassova, Henrik Skjødt, Kim Hørslev-Petersen

Publikováno v: Axelsen, M B, Ejbjerg, B J, Hetland, M L, Skjødt, H, Majgaard, O, Lauridsen, U B, Hørslev-Petersen, K, Boesen, M, Kubassova, O, Bliddal, H & Østergaard, M 2014, ' Differentiation between early rheumatoid arthritis patients and healthy persons by conventional and dynamic contrast-enhanced magnetic resonance imaging ', Scandinavian Journal of Rheumatology, vol. 43, no. 2, pp. 109-118 . https://doi.org/10.3109/03009742.2013.824022

Objectives: To identify the magnetic resonance imaging (MRI) parameter that best differentiates healthy persons and patients with early rheumatoid arthritis (RA), and to investigated responsiveness to treatment of various MRI parameters. Method:Conve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d485c6877cc1540189762eefd38c465
https://portal.findresearcher.sdu.dk/da/publications/1ba284d1-1922-4abd-aed5-e143525bbf67

Zobrazit plný text záznamu

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors

Publikováno v: Pedersen, S J, Sørensen, I J, Garnero, P, Johansen, J S, Madsen, O R, Tvede, N, Hansen, M S, Thamsborg, G, Andersen, L S, Majgaard, O, Loft, A G R, Erlendsson, J, Asmussen, K, Jurik, A G, Møller, J, Hasselquist, M, Mikkelsen, D, Skjødt, T, Lambert, R, Hansen, A & Ostergaard, M 2011, ' ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF{alpha} inhibitors ', Annals of the Rheumatic Diseases, vol. 70, no. 8, pp. 1375-81 . https://doi.org/10.1136/ard.2010.138883
Pedersen, S J, Sørensen, I J, Garnero, P, Johansen, J S, Madsen, O R, Tvede, N, Hansen, M S, Thamsborg, G, Andersen, L S, Majgaard, O, Loft, A G, Erlendsson, J, Asmussen, K, Jurik, A G, Møller, J R, Hasselquist, M, Mikkelsen, D, Skjødt, T, Lambert, R, Hansen, A & Østergaard, M 2011, ' ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors ', Annals of the Rheumatic Diseases, vol. 70, no. 8, pp. 1375-81 . https://doi.org/10.1136/ard.2010.138883

Objectives To investigate the relation between ankylosing spondylitis disease activity score (ASDAS), Bath ankylosing spondylitis disease activity index (BASDAI) and treatment response and biomarkers of inflammation (C-reactive protein (CRP), interle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db9c93bf7edbbbfd1d40ff6dbf007c3
https://pubmed.ncbi.nlm.nih.gov/21551511

Zobrazit plný text záznamu

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis:Results from af 2 year randomized controlled trial (CIMESTRA)

Publikováno v: Hetland, M L, Ejbjerg, B J, Hørslev-Petersen, K, Jacobsen, S, Vestergaard, A, Jurik, A G, Stengaard-Pedersen, K, Junker, P, Lottenburger, T, Hansen, I, Andersen, L S, Tarp, U, Skjødt, H, Pedersen, J K, Majgaard, O, Svendsen, A J, Ellingsen, T, Lindegaard, H M, Christensen, A F, Vallø, J, Torfing, T, Narvestad, E, Thomsen, H S & Ostergaard, M 2008, ' MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis : Results from af 2 year randomized controlled trial (CIMESTRA). ', Annals of the Rheumatic Diseases, vol. 68, no. 3, pp. 384-390 . https://doi.org/10.1136/ard.2008.088245
Hetland, M L, Ejbjerg, B J, Hørslev-Petersen, K, Jacobsen, S, Vestergaard, A, Jurik, A G, Stengaard-Pedersen, K, Junker, P, Lottenburger, T, Hansen, I, Andersen, L S, Tarp, U, Skjødt, H, Pedersen, J K, Majgaard, O, Svendsen, A J, Ellingsen, T, Lindegaard, H M, Christensen, A F, Vallø, J, Torfing, T, Narvestad, E, Thomsen, H S & Ostergaard, M 2008, ' MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA) ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/ard.2008.088245

Objective:To identify predictors of radiographic progression in a 2-year randomised, double-blind, clinical study (CIMESTRA) of patients with early rheumatoid arthritis (RA).Methods:Patients with early RA (n = 130) were treated with methotrexate, int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a178220341fe74c59c434c9a19f1c84
https://portal.findresearcher.sdu.dk/da/publications/0d8e53d0-4440-11dd-9fbe-000ea68e967b

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání